Page last updated: 2024-09-03

mozavaptan and thromboxane b2

mozavaptan has been researched along with thromboxane b2 in 1 studies

Compound Research Comparison

Studies (mozavaptan)	Trials (mozavaptan)	Recent Studies (post-2010) (mozavaptan)	Studies (thromboxane b2)	Trials (thromboxane b2)	Recent Studies (post-2010) (thromboxane b2)
165	8	24	7,483	715	485

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Shimizu, K	1

Trials

1 trial(s) available for mozavaptan and thromboxane b2

Article	Year
Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans. Kidney international, 1995, Volume: 48, Issue:1 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Angiotensin II; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Calcium; Creatinine; Dinoprostone; Epinephrine; Heart Rate; Humans; Male; Norepinephrine; Osmolar Concentration; Phosphates; Potassium; Sodium; Thromboxane B2; Uric Acid; Urine; Water; Water Deprivation	1995

Article

Year

Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.

Kidney international, 1995, Volume: 48, Issue:1

Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Angiotensin II; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Calcium; Creatinine; Dinoprostone; Epinephrine; Heart Rate; Humans; Male; Norepinephrine; Osmolar Concentration; Phosphates; Potassium; Sodium; Thromboxane B2; Uric Acid; Urine; Water; Water Deprivation

1995